Electrocardiographic abnormalities and coronary heart disease mortality among hypertensive men in the Multiple Risk

P M Rautaharju1, J D Neaton

  • 1Department of Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia.

Insights

The Multiple Risk Factor Intervention Trial found that intensive hypertension control may increase coronary heart disease death risk in hypertensive men with certain ECG abnormalities. However, an ischemic ST response to exercise showed a beneficial effect.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Clinical Trials

Background:

  • The Multiple Risk Factor Intervention Trial (MRFIT) studied 12,286 high-risk middle-aged men for primary prevention of heart attack.
  • Two-thirds of participants were hypertensive at entry, with some receiving special intervention (SI) or usual care (UC).

Purpose of the Study:

  • To investigate the impact of electrocardiogram (ECG) abnormalities on coronary heart disease (CHD) mortality in hypertensive men undergoing intervention.
  • To determine if specific ECG findings modify the effectiveness of hypertension control.

Main Methods:

  • Analysis of ECG data from the Dalhousie ECG program within the MRFIT trial.
  • Comparison of CHD death risk between hypertensive SI and UC groups, stratified by ECG abnormalities.
  • Statistical analysis to assess relative risks and differences between groups.

Main Results:

  • Hypertensive SI men with certain resting ECG abnormalities (e.g., repolarization issues, U wave changes) showed a potentially increased risk of CHD death compared to UC.
  • An ischemic ST response to exercise was associated with a lower relative risk of CHD death in SI men (1.35) versus UC men (2.96).
  • Overall, hypertensive SI men with any ECG abnormalities had a higher CHD death risk (RR 3.30) than those without, while UC men showed a lower risk (RR 1.22).

Conclusions:

  • The effect of ECG abnormalities on hypertension intervention response is heterogeneous.
  • Resting ECG abnormalities may indicate reduced effectiveness or adverse outcomes with intensive hypertension control.
  • An ischemic ST response to exercise might predict a beneficial outcome from intensive hypertension management.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...